HAP Trading’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,300
Closed -$45K 2041
2020
Q4
$45K Buy
+10,300
New +$3.16M ﹤0.01% 1440
2020
Q3
Sell
-9,900
Closed -$229K 1656
2020
Q2
$229K Sell
9,900
-103,000
-91% -$27.5M 0.01% 653
2020
Q1
$1.98M Buy
112,900
+12,300
+12% +$3.35M 0.13% 127
2019
Q4
$81K Buy
100,600
+4,300
+4% +$1.18M ﹤0.01% 601
2019
Q3
$3.98M Sell
96,300
-300
-0.3% -$82.2K 0.32% 60
2019
Q2
$1.88M Buy
96,600
+1,400
+1% +$382K 0.14% 122
2019
Q1
$1.86M Buy
+95,200
New +$27.5M 0.17% 123

Other funds holding ELV

HAP Trading's ELV Position: Q2 2020 in Review

HAP Trading sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 62,579 shares — an estimated $16.7M sold.

HAP Trading first reported a position in ELV in Q2 2013 and held it in 7 quarters. The position peaked at $39.2M in Q1 2014. 1,107 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • HAP Trading reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • HAP Trading sold 62,579 Elevance Health shares in Q2 2020, an estimated $16.7M.
  • HAP Trading first reported a position in Elevance Health in Q2 2013 and held it in 7 quarters.
  • HAP Trading's Elevance Health position peaked at $39.2M in Q1 2014.
  • 1,107 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on HAP Trading's 13F filing for Q2 2020, filed 10 Aug 2020.